These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30641146)

  • 1. A Pilot Study of the Effect of an Educational Web Application on Asthma Control and Medication Adherence.
    Weinstein AG; Singh A; Laurenceau JP; Skoner DP; Maiolo J; Sharara R; Ma K; Cheema T; Butler E; Kong A; Thakkar P; Gentile DA
    J Allergy Clin Immunol Pract; 2019; 7(5):1497-1506. PubMed ID: 30641146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate.
    Weinstein CLJ; Ryan N; Shekar T; Gates D; Lane SJ; Agache I; Nathan RA;
    J Allergy Clin Immunol; 2019 Apr; 143(4):1395-1402. PubMed ID: 30537475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of change in asthma control among adolescents and adults with persistent asthma in mometasone furoate/formoterol fumarate clinical trials.
    Wyrwich KW; Ireland AM; Navaratnam P; Nolte H; Gates DF
    J Asthma; 2011 Feb; 48(1):48-56. PubMed ID: 21039190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
    Kosoglou T; Hubbell J; Cutler DL; Johnson-Levonas AO; Xu D; Kantesaria BS; Kim K; Miller SD
    Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device.
    Kosoglou T; Hubbell J; Johnson-Levonas AO; Yunan M; Kantesaria BS; Cutler DL
    Clin Pharmacol Drug Dev; 2014 May; 3(3):222-8. PubMed ID: 27128612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids.
    Weinstein SF; Corren J; Murphy K; Nolte H; White M;
    Allergy Asthma Proc; 2010; 31(4):280-9. PubMed ID: 20687982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Findings from a pilot Randomised trial of an Asthma Internet Self-management Intervention (RAISIN).
    Morrison D; Wyke S; Saunderson K; McConnachie A; Agur K; Chaudhuri R; Thomas M; Thomson NC; Yardley L; Mair FS
    BMJ Open; 2016 May; 6(5):e009254. PubMed ID: 27173807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.
    Karpel JP; Busse WW; Noonan MJ; Monahan ME; Lutsky B; Staudinger H
    Ann Pharmacother; 2005 Dec; 39(12):1977-83. PubMed ID: 16264062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids.
    Nathan RA; Nolte H; Pearlman DS;
    Allergy Asthma Proc; 2010; 31(4):269-79. PubMed ID: 20678306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial.
    Lavoie KL; Moullec G; Lemiere C; Blais L; Labrecque M; Beauchesne MF; Pepin V; Cartier A; Bacon SL
    Patient Prefer Adherence; 2014; 8():1555-69. PubMed ID: 25422587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence.
    Pakpour AH; Gholami M; Esmaeili R; Naghibi SA; Updegraff JA; Molloy GJ; Dombrowski SU
    Epilepsy Behav; 2015 Nov; 52(Pt A):133-42. PubMed ID: 26414343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler.
    Bousquet J; D'Urzo A; Hebert J; Barraza CH; Boulet LP; Suárez-Chacón R; Harnest U; Lundbäck B; Martinez Morales G; Nieminen MM; Nolop KB; Visser S; Lutsky BN
    Eur Respir J; 2000 Nov; 16(5):808-16. PubMed ID: 11153576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a web-based asthma self-management system: a randomised controlled pilot trial.
    Wiecha JM; Adams WG; Rybin D; Rizzodepaoli M; Keller J; Clay JM
    BMC Pulm Med; 2015 Feb; 15():17. PubMed ID: 25885418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma.
    Foster JM; Usherwood T; Smith L; Sawyer SM; Xuan W; Rand CS; Reddel HK
    J Allergy Clin Immunol; 2014 Dec; 134(6):1260-1268.e3. PubMed ID: 25062783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Providing feedback on adherence increases use of preventive medication by asthmatic children.
    Burgess SW; Sly PD; Devadason SG
    J Asthma; 2010 Mar; 47(2):198-201. PubMed ID: 20170329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effectiveness of Web-Based Asthma Self-Management System, My Asthma Portal (MAP): A Pilot Randomized Controlled Trial.
    Ahmed S; Ernst P; Bartlett SJ; Valois MF; Zaihra T; Paré G; Grad R; Eilayyan O; Perreault R; Tamblyn R
    J Med Internet Res; 2016 Dec; 18(12):e313. PubMed ID: 27908846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects.
    Kosoglou T; Hubbell J; Kantesaria B; Hanson ME; Cutler DL
    Clin Pharmacol Drug Dev; 2014 May; 3(3):229-34. PubMed ID: 27128613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma.
    Berger WE; Bensch GW; Weinstein SF; Skoner DP; Prenner BM; Shekar T; Nolte H; Teper AA
    Pediatr Pulmonol; 2014 May; 49(5):441-50. PubMed ID: 24019197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Detroit Young Adult Asthma Project: Pilot of a Technology-Based Medication Adherence Intervention for African-American Emerging Adults.
    Kolmodin MacDonell K; Naar S; Gibson-Scipio W; Lam P; Secord E
    J Adolesc Health; 2016 Oct; 59(4):465-71. PubMed ID: 27475032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.